Earningsreport

Q2/2019 6/30/2019 EPS -0.380 ZacksConsensus -0.170 ActVsEst (0.210) - Miss

Titan Pharmaceuticals, Inc.  (TTNP) 
NASDAQ:AMEX Investor Relations: ir.titanpharm.com